» Articles » PMID: 12669274

KLOTHO Allele Status and the Risk of Early-onset Occult Coronary Artery Disease

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2003 Apr 2
PMID 12669274
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

We previously identified a functional variant of KLOTHO (termed "KL-VS"), which harbors two amino acid substitutions in complete linkage disequilibrium and is associated with reduced human longevity when in homozygosity. Klotho-deficient mice display extensive arteriosclerosis when fed a normal diet, suggesting a potent genetic predisposition. To determine whether klotho influences atherosclerotic risk in humans, we performed cross-sectional studies to assess the association between the KL-VS allele and occult coronary artery disease (CAD) in two independent samples of apparently healthy siblings of individuals with early-onset (age <60 years) CAD (SIBS-I [N=520] and SIBS-II [N=436]). Occult CAD was defined as the occurrence of a reversible perfusion defect during exercise thallium scintigraphy and/or as an abnormal result of an exercise electrocardiogram (SIBS-I, n=97; SIBS-II, n=56). In SIBS-I, the KL-VS allele conferred a relative odds of 1.90 (95% confidence interval 1.21-2.98) for occult CAD, after adjusting for familial intraclass correlations (P<.005). Logistic regression modeling, incorporating known CAD risk factors, demonstrated that the KL-VS allele is an independent risk factor (P<.019) and that the imposed risk of KL-VS allele status is influenced by modifiable risk factors. Hypertension (P<.022) and increasing high-density lipoprotein cholesterol (HDL-C) levels (P<.022) mask or reduce the risk conferred by the KL-VS allele, respectively, whereas current smoking (P<.004) increases the risk. Remarkably concordant effects of the KL-VS allele and modifying factors on the risk of occult CAD were seen in SIBS-II. These results demonstrate that the KL-VS allele is an independent risk factor for occult CAD in two independent high-risk samples. Modifiable risk factors, including hypertension, smoking status, and HDL-C level, appear to influence the risk imposed by this allele.

Citing Articles

Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial.

Donate-Correa J, Ferri C, Mora-Fernandez C, Perez-Delgado N, Gonzalez-Luis A, Navarro-Gonzalez J Cardiovasc Diabetol. 2024; 23(1):314.

PMID: 39182114 PMC: 11344929. DOI: 10.1186/s12933-024-02393-x.


The association of platelet count, high-density lipoprotein cholesterol, and platelet/high-density lipoprotein cholesterol ratio with serum soluble Klotho.

Huang C, Guan Y, Chen L, Xu Y, Yang H Lipids Health Dis. 2024; 23(1):251.

PMID: 39153988 PMC: 11330610. DOI: 10.1186/s12944-024-02242-6.


Association of gene variants with metabolic and renal function parameters in Mexican patients living with type 2 diabetes.

Mendoza-Carrera F, Farias-Basulto A, Gomez-Garcia E, Rizo De la Torre L, Cueto-Manzano A, Cortes-Sanabria L J Diabetes Metab Disord. 2024; 23(1):1125-1131.

PMID: 38932797 PMC: 11196432. DOI: 10.1007/s40200-024-01398-3.


Determination of the Relationship Between DNA Methylation Status of and Genes With Hypertension.

Osum M, Tosun O, Birtan H, Kalkan R Balkan J Med Genet. 2024; 26(2):41-50.

PMID: 38482265 PMC: 10932598. DOI: 10.2478/bjmg-2023-0024.


Change in circulating klotho in response to weight loss, with and without exercise, in adults with overweight or obesity.

Collins K, Ambrosio F, Rogers R, Lang W, Schelbert E, Davis K Front Aging. 2023; 4:1213228.

PMID: 37457921 PMC: 10347392. DOI: 10.3389/fragi.2023.1213228.


References
1.
Fukino K, Suzuki T, Saito Y, Shindo T, Amaki T, Kurabayashi M . Regulation of angiogenesis by the aging suppressor gene klotho. Biochem Biophys Res Commun. 2002; 293(1):332-7. DOI: 10.1016/S0006-291X(02)00216-4. View

2.
McCombs R, Marcadis D, Ellis J, Weinberg R . Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N Engl J Med. 1994; 331(11):706-10. DOI: 10.1056/NEJM199409153311104. View

3.
WOODS M, Harris K, Ahluwalia J, Schmelzle K, Mayo M . Smoking in urban African Americans: behaviors, gender differences, and motivation to quit. Ethn Dis. 2001; 11(3):532-9. View

4.
Hines L, Stampfer M, Ma J, Gaziano J, Ridker P, Hankinson S . Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001; 344(8):549-55. DOI: 10.1056/NEJM200102223440802. View

5.
Brunner H . Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. Am J Cardiol. 2001; 87(8A):3C-9C. DOI: 10.1016/s0002-9149(01)01538-7. View